Medical Science Liaison, Oncology - Lung & GU Tumors North Texas

Medical Science Liaison, Oncology – Lung & GU Tumors

Location Field – Central & North Texas

The primary role of the Medical Science Liaison (MSL) is to engage in meaningful peer‑to‑peer scientific dialogue with healthcare system leaders such as Regional Thought Leaders (RTLs), National Thought Leaders, and Healthcare Professional (HCPs) within a defined geography to translate science into patient care. MSLs will also engage the top HCPs in high‑disease burden hospitals and act as a clinical & scientific advisor to cross‑functional partners, supporting medical community conversations throughout pre‑ and peri‑launch activities and beyond.

• Effectively collaborate and engage in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch.
• Proactively engage in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and LCM activities.
• Engage with medical societies, PAGs (Patient Advocacy Groups) and guideline committee members as appropriate.
• Provide training for external speakers as needed.
• Strategically engage payers in the pre‑ and peri‑launch phases (with FHEOR and Account Executives).
• Provide medical support to address unsolicited HCP questions in real‑time, both in face‑to‑face interactions and through the Medical on Call virtual capability.
• Develop credible connections with key Thought Leaders (TLs) in oncology through high‑quality peer‑to‑peer scientific dialogue.
• Appropriately document and achieve annual goals.
• Leverage digital capabilities to enhance medical engagement.

• Provide recommendations and insights to clinical development team on study feasibility within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators.
• liaise with key large accounts to understand clinical barriers to patient access and ensuring equity in access to clinical trials.
• Lead major evidence read‑outs with clinical trial investigators (e.g., Phase 3 top‑line data).
• Support Interventional and Non‑Interventional Research (NIR) studies (e.g., identification and assessment of potential study sites) to facilitate patient recruitment.
• Support HCPs in the ISR submission and execution process and study follow‑up.
• Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified adverse events.
• If applicable, support CRO‑sponsored studies as agreed with the home office.

• MD, PharmD, PhD, APP, PA, NP with experience in a specific disease area or with a broad medical background or relevant pharmaceutical experience.
• Working in a scientific and/or clinical research environment; field medical expertise preferred.
• Deep understanding of TL environment and needs.

• Scientific or clinical disease area knowledge, patient treatment trends, clinical landscape.
• Pharmaceutical industry experience including compliance and regulatory guidelines.

• Clinical trial design and process.
• Understanding of national and regional healthcare and access environment.

• Requires operation of a company‑provided vehicle and meeting qualification as a "Qualified Driver" (age 21+, valid driver’s license, acceptable risk level).
• MSL will spend majority of time in the field with external customers, with additional requirements based on territory assignment and team needs.

• Engage in a dialogue about data in a compelling, fair and balanced way.
• Expert knowledge of clinical practice and evolving healthcare delivery models.
• Understand and critically appraise scientific publications.
• Knowledge of clinical trial design and methodology, including Good Clinical Practices and regulatory requirements.
• Understand treatment paradigms, competitive landscape and frame information in a convincing and…